Riskpilot← Back to searchSign inGet full accessPHYSIOTECH AS
ASActiveOrg 888489142Øvre Høn Terrasse 22, 1384 AskerWholesale of pharmaceutical and medical goods · NACE 4646Est. 20050 employeeswww.physiotech.no
Revenue 2024
NOK 0
EBITDA margin
—
-10% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK 2,7M
+135% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -215K | -10% |
| Net profit | NOK 2,7M | +135% |
| Total assets | NOK 23,5M | +13% |
| Equity | NOK 23,5M | +13% |
| Employees | 0 | — |
Legal name
PHYSIOTECH AS
Org number
888489142
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15. august 2005
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Utvikling, markedsføring, engros- og detaljhandel med medisinsk utstyr, samt rådgivning, undervisning, agenturvirksomhet og deltakelse i andre selskaper innenfor helsesektoren. Herunder også drive med investeringsvirksomhet.
Address
Øvre Høn Terrasse 22, 1384 Asker
Website
www.physiotech.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 102 | 129 | 510 | 7 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −67 | −83 | 250 | −195 | −215 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −67 | −83 | 250 | −195 | −215 |
| Net financials | 2 994 | 3 | 40 362 | 1 348 | 2 929 |
| Profit before tax | 2 927 | −81 | 40 612 | 1 153 | 2 713 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 2 927 | −81 | 40 612 | 1 153 | 2 713 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 762 | 10 664 | 20 634 | 20 812 | 23 480 |
| Equity | 10 735 | −6 | 20 606 | 20 759 | 23 472 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 10 670 | 28 | 53 | 7 |
| Total debt | 27 | 10 670 | 28 | 53 | 7 |
EBITDA margin
-21538900.0%
This company
15.8%
Market median
-136322252% vs market
20202024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20202024
Return on equity
11.6%
This company
18.4%
Market median
+37% vs market
20202024
Net profit margin
271320300.0%
This company
8.1%
Market median
+3349633233% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Former (1) | ||
| Chairman | 2005 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHYSIOTECH AS 
TEKMAS ASBoard members of PHYSIOTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anne Cathrine Bergh | Board of Directors | 0 companies |
| Kjell Magne Hofsli | Chairman | 0 companies |
| Erik Bergh | Chairman | 0 companies |